Daily Derm Times: May 9, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Missed Diagnoses, Missed Opportunities: Closing the Gap in Skin Cancer for Patients of Color

Explore the urgent need for improved skin cancer awareness and care for minority populations, addressing disparities in diagnosis and treatment.

Study Highlights Unmet Needs in Measuring Patient Experiences in Alopecia Areata

Significant unmet needs were found among high-quality validation studies on the internal structure of PROMs specific to alopecia areata.

Outgoing AAD President Seemal Desai, MD, FAAD, Reflects on Challenges, Advocacy, and the Future of Dermatology

Desai reflects on his AAD presidency, addressing Medicare challenges, technological advancements, and the future of dermatology leadership.

Artax Presents Phase 2a Results of AX-158 for Plaque Psoriasis

The promising safety and efficacy results were presented at the Society for Investigative Dermatology 2025 Annual Meeting.

Collaborating for Better Aesthetics: Why Dermatology Matters in Multispecialty Medicine

Explore the evolving landscape of dermatology as experts emphasize the importance of cross-specialty collaboration and patient-centered care in aesthetic medicine.

Icotrokinra Effective in High-Impact Psoriasis Areas

Johnson & Johnson's icotrokinra shows promising results in treating moderate plaque psoriasis, especially in challenging areas like the scalp and genitals.

New-Onset Psoriasis After Abrocitinib Treatment for Atopic Dermatitis

Abrocitinib’s targeted inhibition of JAK1 offers effective control of AD, but may, in rare instances, lead to a shift in immune expression resulting in paradoxical psoriasis.